VieCure Raises $43 Million to Expand Precision Medicine in Cancer Care

VieCure secures $43 million funding led by Mitch Rales and Northpond Ventures to democratize precision medicine in community cancer care practices. Mitch Rales and Dr. Howard 'Skip' Burris III join Board of Directors.